QCLS is a binary photonic-compute moonshot: revolutionary performance-per-watt upside if its LightSolver-licensed laser platform and in-house OPU reach commercialization—total-loss risk if they don’t.
Overview
QCLS is a micro-cap undergoing a dramatic reinvention: formerly a pharmaceutical entity (TNF Pharmaceuticals/MyMD), it pivoted in Sept 2025 to “quantum-class” and photonic computing infrastructure. Its near-term cornerstone asset is an exclusive global license with LightSolver (WEF 2025 Technology Pioneer) to adapt laser-based computing for crypto/blockchain. The technology uses laser interference to solve optimization and mathematical problems, with claimed advantages of up to ~100x speed and ~1/100th energy vs conventional GPU approaches. QCLS is pre-revenue and currently funds operations via R&D spend and complex financing (convertible preferred/warrants). The upside case is disruptive performance-per-watt compute for AI/crypto; the downside case is failure to commercialize, heavy dilution, and going-concern risk.